AJR Am J Roentgenol
- CHOU SS
Editorial Comment: The Time Is Almost Ripe to Mainstream Diffusion in Routine
Breast MRI.
AJR Am J Roentgenol. 2023 Nov 1. doi: 10.2214/AJR.23.30445.
- LANGMAN EL, Johnson KS, Dinome ML
Retained Biopsy Site Markers After Breast Lesion Surgical Resection: Associations
With Residual Malignancy.
AJR Am J Roentgenol. 2024;222:e2329670.
- BUTLER RS
Editorial Comment: Artificial Intelligence May Help Define Screening Strategies
in Patients With Dense Breasts.
AJR Am J Roentgenol. 2024;222:e2330042.
- LEE SE, Yoon JH, Son NH, Han K, et al
Screening in Patients With Dense Breasts: Comparison of Mammography, Artificial
Intelligence, and Supplementary Ultrasound.
AJR Am J Roentgenol. 2023 Jul 26. doi: 10.2214/AJR.23.29655.
- PHILPOTTS LE
Beyond the AJR: Patient Cost-Sharing Adversely Affects Adherence to Downstream
Imaging After Mammography Screening.
AJR Am J Roentgenol. 2023 May 31. doi: 10.2214/AJR.23.29685.
Ann Surg Oncol
- ROLDAN-VASQUEZ E, Bharani T, Mitri S, Flores R, et al
Expanding Access to Immediate Lymphatic Reconstruction Through an Axillary
Surgery Referral Program: A 6-Year Single-Center Experience.
Ann Surg Oncol. 2024;31:2025-2031.
- CARTER MM, Whitrock JN, Pratt CG, Shaughnessy EA, et al
Nationwide Analysis of Locoregional Management for Ductal Carcinoma In Situ in
Males: An NCDB Analysis of the Surgical Approach to DCIS in Males.
Ann Surg Oncol. 2024;31:1599-1607.
- GOLDHABER N, O'Keefe T, Blair S
Reply to: "Is Choosing Wisely Wise for Lobular Carcinoma in Patients Over 70
Years of Age? A National Cancer Database Analysis of Sentinel Node Practice
Patterns.
Ann Surg Oncol. 2024;31:1669-1670.
- SPIEKERMAN VAN WEEZELENBURG MA, Bakens MJAM, Daemen JHT, Aldenhoven L, et al
Prevention of Seroma Formation and Its Sequelae After Axillary Lymph Node
Dissection: An Up-to-Date Systematic Review and Guideline for Surgeons.
Ann Surg Oncol. 2024;31:1643-1652.
- CHO JH, Park JM, Park HS, Kim HJ, et al
ASO Visual Abstract: Oncologic Outcomes in Nipple-Sparing Mastectomy with
Immediate Reconstruction and Total Mastectomy with Immediate Reconstruction in
Women with Breast Cancer: A Machine Learning Analysis.
Ann Surg Oncol. 2024 Feb 8. doi: 10.1245/s10434-024-14982.
- CARTER MM, Whitrock JN, Pratt CG, Shaughnessy EA, et al
ASO Visual Abstract: Nationwide Analysis of Locoregional Management for Ductal
Carcinoma In Situ (DCIS) in Males-An NCDB Analysis of the Surgical Approach to
DCIS in Males.
Ann Surg Oncol. 2024;31:1663-1664.
- VORSTENBOSCH J, Ghione P, Plitas G, Horwitz S, et al
Surgical Management and Long-Term Outcomes of BIA-ALCL: A Multidisciplinary
Approach.
Ann Surg Oncol. 2024;31:2032-2040.
- PALMQUIST E, Sevilimedu V, Garcia P, Le T, et al
Patient-Reported Outcomes in Patients Undergoing Lumpectomy With and Without
Defect Closure.
Ann Surg Oncol. 2024;31:1615-1622.
Anticancer Res
- FRITSCH H, Celik M, Warm M, Thangarajah F, et al
Sonographic Assessment of Breast Implants Using Strain Elastography and Shear
Wave Elastography in an Animal Model.
Anticancer Res. 2024;44:497-501.
BMC Cancer
- JIANG Y, Liu J, Chen L, Qian Z, et al
A promising target for breast cancer: B7-H3.
BMC Cancer. 2024;24:182.
- KIM MW, Lee H, Lee S, Moon S, et al
Drug-resistant profiles of extracellular vesicles predict therapeutic response in
TNBC patients receiving neoadjuvant chemotherapy.
BMC Cancer. 2024;24:185.
- LU Y, Hui B, Yang D, Li Y, et al
Efficacy and safety analysis of hypofractionated and conventional fractionated
radiotherapy in postoperative breast cancer patients.
BMC Cancer. 2024;24:181.
- ABBOAH-OFFEI M, Bayuo J, Salifu Y, Afolabi O, et al
Experiences and perceptions of men following breast cancer diagnosis: a mixed
method systematic review.
BMC Cancer. 2024;24:179.
BMJ
- FREEMAN K, Jenkinson D, Clements K, Wallis MG, et al
Atypia detected during breast screening and subsequent development of cancer:
observational analysis of the Sloane atypia prospective cohort in England.
BMJ. 2024;384:e077039.
Br J Cancer
- AXELSEN TV, Olesen C, Khan D, Mohammadi A, et al
Antibodies toward Na(+),HCO(3)(-)-cotransporter NBCn1/SLC4A7 block net acid
extrusion and cause pH-dependent growth inhibition and apoptosis in breast
cancer.
Br J Cancer. 2024 Feb 3. doi: 10.1038/s41416-024-02591.
Breast Cancer
- IWAMOTO T, Kumamaru H, Niikura N, Sagara Y, et al
Survival trends and patient characteristics between 2004 and 2016 for breast
cancer in Japan based on the National Clinical Database-Breast Cancer Registry.
Breast Cancer. 2024 Feb 6. doi: 10.1007/s12282-024-01545.
- YU T, Rui L, Jiumei Z, Ziwei L, et al
Advances in the study of autophagy in breast cancer.
Breast Cancer. 2024 Feb 5. doi: 10.1007/s12282-023-01541.
- ZHUANG JY, Huang ZN, Weng ZJ, Liu MM, et al
Expression and clinical significance of hypoxia-induced long non-coding RNA
TCONS_I2_00001955 in breast cancer.
Breast Cancer. 2024 Feb 4. doi: 10.1007/s12282-023-01540.
Breast Cancer Res
- LEE J, Nishikawa RM
Improving lesion detection in mammograms by leveraging a Cycle-GAN-based lesion
remover.
Breast Cancer Res. 2024;26:21.
- QIAN J, Ma Y, Tahaney WM, Moyer CL, et al
The novel phosphatase NUDT5 is a critical regulator of triple-negative breast
cancer growth.
Breast Cancer Res. 2024;26:23.
- LUNDBERG P, Abrahamsson A, Kihlberg J, Tellman J, et al
Low-dose acetylsalicylic acid reduces local inflammation and tissue perfusion in
dense breast tissue in postmenopausal women.
Breast Cancer Res. 2024;26:22.
- RONNLUND C, Sifakis EG, Schagerholm C, Yang Q, et al
Prognostic impact of HER2 biomarker levels in trastuzumab-treated early
HER2-positive breast cancer.
Breast Cancer Res. 2024;26:24.
- SANTERAMO R, Damiani C, Wei J, Montana G, et al
Are better AI algorithms for breast cancer detection also better at predicting
risk? A paired case-control study.
Breast Cancer Res. 2024;26:25.
Breast Cancer Res Treat
- HWANG YH, Yoo TK, Lee SB, Kim J, et al
Comparison of long-term oncological outcomes after central lumpectomy versus
nipple-sparing breast-conserving surgery for centrally located breast cancer: a
propensity score-matched study.
Breast Cancer Res Treat. 2024 Feb 8. doi: 10.1007/s10549-024-07267.
- GOYAL RK, Zhang J, Davis KL, Sluga-O'Callaghan M, et al
Real-world treatment patterns and clinical outcomes in patients treated with
eribulin after prior phosphoinositide 3-Kinase inhibitor treatment for metastatic
breast cancer.
Breast Cancer Res Treat. 2024 Feb 4. doi: 10.1007/s10549-023-07080.
- SIVAKANTHAN T, Tanner J, Mahata B, Agrawal A, et al
Investigating the role of tumour-to-skin proximity in predicting nodal metastasis
in breast cancer.
Breast Cancer Res Treat. 2024 Feb 3. doi: 10.1007/s10549-023-07230.
Breast J
- DILAVERI C, Degnim A, Lee C, DeSimone D, et al
Idiopathic Granulomatous Mastitis.
Breast J. 2024;2024:6693720.
Cancer
- NGUYEN SM, Tran HTT, Long J, Shrubsole MJ, et al
Gut microbiome in association with chemotherapy-induced toxicities among patients
with breast cancer.
Cancer. 2024 Feb 6. doi: 10.1002/cncr.35229.
- VERSLUIS MAJ, Raijmakers NJH, Baars A, van den Beuken-van Everdingen MHJ, et al
Trajectories of health-related quality of life and symptom burden in patients
with advanced cancer towards the end of life: Longitudinal results from the
eQuiPe study.
Cancer. 2024;130:609-617.
Cancer Chemother Pharmacol
- ELKASAR AO, Hussien FZ, Abdel-Hamied HE, Saleh IG, et al
Effect of lithium on chemotherapy-induced neutropenia in Egyptian breast cancer
patients; a prospective clinical study.
Cancer Chemother Pharmacol. 2024 Feb 7. doi: 10.1007/s00280-023-04620.
Cancer Epidemiol Biomarkers Prev
- PEILA R, Rohan TE
Metabolic Syndrome and the Risk of Ductal Carcinoma In Situ of the Breast in the
UK Biobank.
Cancer Epidemiol Biomarkers Prev. 2024;33:333-336.
- DEVASIA TP, Howlader N, Dewar RA, Stevens JL, et al
Increase in the Life Expectancy of Patients with Cancer in the United States.
Cancer Epidemiol Biomarkers Prev. 2024;33:196-205.
Cancer Lett
- TAN Z, Boyapati K, Tressler CM, Jenkinson N, et al
Glutamine transporter SLC38A3 promotes breast cancer metastasis via
Gsk3beta/beta-catenin/EMT pathway.
Cancer Lett. 2024 Feb 1:216653. doi: 10.1016/j.canlet.2024.216653.
- BAHREYNI A, Mohamud Y, Luo H
Oncolytic virus-based combination therapy in breast cancer.
Cancer Lett. 2024 Feb 1:216634. doi: 10.1016/j.canlet.2024.216634.
Cancer Res
- GEDIK ME, Saatci O, Oberholtzer N, Uner M, et al
Targeting TACC3 induces immunogenic cell death and enhances T-DM1 response in
HER2-positive breast cancer.
Cancer Res. 2024 Feb 6. doi: 10.1158/0008-5472.CAN-23-2812.
- BERNARD MJ, Goldstein AS
A metabolic-epigenetic mechanism directs cell fate and therapeutic sensitivity in
breast cancer.
Cancer Res. 2024 Feb 8. doi: 10.1158/0008-5472.CAN-24-0460.
Clin Breast Cancer
- KNOWLES AJ
Advocating for Enhanced Patient Engagement in Breast Cancer Care: Impact of
Residual Increased Lateral Adiposity and Consideration of the Pursuit of "Living
Flat".
Clin Breast Cancer. 2024 Jan 17:S1526-8209(24)00003.
- PLOUMAKI I, Triantafyllou E, Koumprentziotis IA, Karampinos K, et al
Cyclin-Dependent Kinase 4/6 Inhibitors as Neoadjuvant Therapy of Hormone
Receptor-Positive/HER2-Negative Early Breast Cancer: What do we Know so Far?
Clin Breast Cancer. 2024 Jan 16:S1526-8209(24)00002.
- XU J, Gan C, Yu S, Yao S, et al
Analysis of Immune Resistance Mechanisms in TNBC: Dual Effects Inside and Outside
the Tumor.
Clin Breast Cancer. 2024;24:e91-e102.
- WANG Y, Peng D, Zhou X, Hu W, et al
Treatments and Prognosis of the Breast Ductal Carcinoma In Situ.
Clin Breast Cancer. 2024;24:122-130.
- MOKBEL K
Unlocking the Power of the Homing Phenomenon: Why Breast Conserving Surgery
Outshines Mastectomy in Overall Survival.
Clin Breast Cancer. 2024;24:85-92.
Clin Med Insights Oncol
- HASONA NA, Elsabahy M, Shaker OG, Zaki O, et al
The Implication of Growth Arrest-Specific 5 rs145204276 Polymorphism and Serum
Expression of Sirtuin 1, Transforming Growth Factor-Beta, and microRNA-182 in
Breast Cancer.
Clin Med Insights Oncol. 2024;18:11795549241227415.
Eur J Cancer
- YANG F, Liu G, Mao F, Zheng YC, et al
Corrigendum to "Re: Pathologic complete responses, long-term outcomes, and
recurrence patterns in HER2-low vs. HER2-zero breast cancer after neoadjuvant
chemotherapy: Several issues about HER2 expression and neoadjuvant chemotherapy
in breast cancer"
Eur J Cancer. 2024 Feb 2:113559. doi: 10.1016/j.ejca.2024.113559.
- RUSAKIEWICZ S, Tyekucheva S, Tissot-Renaud S, Chaba K, et al
Multiplexed high-throughput immune cell imaging in patients with high-risk triple
negative early breast cancer: Analysis from the International Breast Cancer Study
Group (IBCSG) Trial 22-00.
Eur J Cancer. 2024;200:113535.
- DIERAS V, Han HS, Wildiers H, Friedlander M, et al
Veliparib with carboplatin and paclitaxel in BRCA-mutated advanced breast cancer
(BROCADE3): Final overall survival results from a randomized phase 3 trial.
Eur J Cancer. 2024;200:113580.
Eur Radiol
- ZHAO S, Li Y, Ning N, Liang H, et al
Association of peritumoral region features assessed on breast MRI and prognosis
of breast cancer: a systematic review and meta-analysis.
Eur Radiol. 2024 Feb 9. doi: 10.1007/s00330-024-10612.
- TONG Y, Hu Z, Wang H, Huang J, et al
Anti-HER2 therapy response assessment for guiding treatment (de-)escalation in
early HER2-positive breast cancer using a novel deep learning radiomics model.
Eur Radiol. 2024 Feb 8. doi: 10.1007/s00330-024-10609.
- MULLEN LA
Can digital breast tomosynthesis decrease interval cancers in a breast cancer
screening program?
Eur Radiol. 2024 Feb 6. doi: 10.1007/s00330-024-10635.
- ZHANG T, Mann RM
Contrast-enhanced mammography: better with AI?
Eur Radiol. 2024;34:914-916.
- XU J, Zhang L, Wen W, He Y, et al
Evaluation of standard breast ultrasonography by adding two-dimensional and
three-dimensional shear wave elastography: a prospective, multicenter trial.
Eur Radiol. 2024;34:945-956.
- BARR RG
Breast elastography: how does it works, and for what purposes?
Eur Radiol. 2024;34:928-929.
Int J Cancer
- SVANOE AA, Humlevik ROC, Knutsvik G, Saele AKM, et al
Age-related phenotypes in breast cancer: A population-based study.
Int J Cancer. 2024 Feb 6. doi: 10.1002/ijc.34863.
- PEILA R, Rohan TE
Circulating levels of biomarkers and risk of ductal carcinoma in situ of the
breast in the UK Biobank study.
Int J Cancer. 2024;154:1191-1203.
Int J Oncol
- ZHANG W, Tang X, Peng Y, Xu Y, et al
GBP2 enhances paclitaxel sensitivity in triple?negative breast cancer by
promoting autophagy in combination with ATG2 and inhibiting the PI3K/AKT/mTOR
pathway.
Int J Oncol. 2024;64:34.
Int J Radiat Oncol Biol Phys
- PETRY V, Bonadio RC, Moutinho K, Leite LS, et al
Frequency of radiotherapy-induced malignancies in Li-Fraumeni Syndrome patients
with early-stage breast cancer and influence of the radiotherapy technique.
Int J Radiat Oncol Biol Phys. 2024 Feb 1:S0360-3016(24)00249.
J Nucl Med
- GEBHART G, Piccart M, Mankoff D
Molecular Imaging in Breast Cancer: Martine Piccart and Geraldine Gebhart Talk
with David Mankoff About 2 Generations of Research.
J Nucl Med. 2024 Feb 8:jnumed.124.267461. doi: 10.2967/jnumed.124.267461.
- GONDRY O, Caveliers V, Xavier C, Raes L, et al
Phase II Trial Assessing the Repeatability and Tumor Uptake of [(68)Ga]Ga-HER2
Single-Domain Antibody PET/CT in Patients with Breast Carcinoma.
J Nucl Med. 2024;65:178-184.
Lancet Oncol
- BAJPAI J, Kapu V, Rath S, Kumar S, et al
Low-dose versus standard-dose olanzapine with triple antiemetic therapy for
prevention of highly emetogenic chemotherapy-induced nausea and vomiting in
patients with solid tumours: a single-centre, open-label, non-inferiority,
randomised, controlled,
Lancet Oncol. 2024;25:246-254.
NPJ Breast Cancer
- FABI A, Carbognin L, Botticelli A, Paris I, et al
Author Correction: Real-world ANASTASE study of atezolizumab+nab-paclitaxel as
first-line treatment of PD-L1-positive metastatic triple-negative breast cancer.
NPJ Breast Cancer. 2024;10:13.
Oncogene
- LAGARDE CB, Kavalakatt J, Benz MC, Hawes ML, et al
Obesity-associated epigenetic alterations and the obesity-breast cancer axis.
Oncogene. 2024 Feb 3. doi: 10.1038/s41388-024-02954.
Proc Natl Acad Sci U S A
- LI SY, Hammarlund JA, Wu G, Lian JW, et al
Tumor circadian clock strength influences metastatic potential and predicts
patient prognosis in luminal A breast cancer.
Proc Natl Acad Sci U S A. 2024;121:e2311854121.
Radiol Artif Intell
- KIM JG, Haslam B, Diab AR, Sakhare A, et al
Impact of a Categorical AI System for Digital Breast Tomosynthesis on Breast
Cancer Interpretation by Both General Radiologists and Breast Imaging
Specialists.
Radiol Artif Intell. 2024 Feb 7:e230137. doi: 10.1148/ryai.230137.
Radiol Cardiothorac Imaging
- HONG YJ, Han K, Lee HJ, Hur J, et al
Assessment of Feasibility and Interscan Variability of Short-time Cardiac MRI for
Cardiotoxicity Evaluation in Breast Cancer.
Radiol Cardiothorac Imaging. 2024;6:e220229.
Radiol Imaging Cancer
- FREITAS V, Li X, Scaranelo A, Au F, et al
Breast Cancer Detection Using a Low-Dose Positron Emission Digital Mammography
System.
Radiol Imaging Cancer. 2024;6:e230020.
- BARRETO DS, Rapelyea JA
Low-Dose Positron Emission Mammography: A Novel, Promising Technique for Breast
Cancer Detection.
Radiol Imaging Cancer. 2024;6:e240006.
Radiother Oncol
- RAUFF SONDERGAARD S, Bechmann T, Maae E, Molby Nielsen AW, et al
Shared decision making with breast cancer patients - does it work? Results of the
cluster-randomized, multicenter DBCG RT SDM trial.
Radiother Oncol. 2024 Feb 3:110115. doi: 10.1016/j.radonc.2024.110115.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016